Assoc. Director / Director, Clinical Development Operations jobs in United States
cer-icon
Apply on Employer Site
company-logo

SAGA Diagnostics · 22 hours ago

Assoc. Director / Director, Clinical Development Operations

SAGA Diagnostics is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analysis of circulating tumor DNA (ctDNA). The Assoc. Director / Director, Clinical Development Operations will oversee the planning, execution, and monitoring of diagnostic aspects of clinical trials in oncology, managing cross-functional teams and vendor relationships to ensure high-quality trial conduct.

BiotechnologyGeneticsMedicalOncology

Responsibilities

Partner with the clinical team to design and execute diagnostic clinical studies supporting product development and regulatory submissions
Develop and manage study plans, budgets, timelines, and resource allocation
Oversee day-to-day operations of clinical trials, ensuring adherence to protocols, GCP, and timelines
Manage clinical specimen shipping and logistics, sample trackers, and coordination with internal laboratory teams
Ensure that documentation and trial activities are audit ready
Collaborate cross-functionally with Regulatory, Quality, Medical Affairs, R&D, Lab Ops, Commercial, etc
Manage CROs, central labs, and clinical sites, including vendor selection, contract negotiation, and performance oversight
Act as the primary operational point of contact for investigators and external collaborators
Contribute to and review key clinical documents (protocols, SAP’s, ICFs, CRFs, monitoring plans)
Ensure full regulatory compliance with FDA, ICH-GCP, CLIA, IVDR, and other applicable standards
Support audit preparation and response in collaboration with Quality and Regulatory teams
Lead initiatives to improve SOPs, systems, and best practices in clinical operations
Identify and resolve operational inefficiencies with scalable, diagnostics-appropriate solutions
Oversee operational aspects of interventional and observational diagnostic clinical trials, including retrospective analyses
Prepare study protocols, informed consent forms, and training materials and SIV documents
Manage the Trial Master File (TMF) and ensure audit/inspection readiness
Oversee specimen logistics: site collection, shipping, accessioning, and processing coordination
Track study performance metrics and resolve issues with vendors or sites as they arise
Collaborate with internal stakeholders to align clinical operations with overall product strategy
Drive regulatory documentation and ensure compliance with IDE, CDx, IVDR, and other standards
Facilitate cross-functional internal and external (study PI’s and sites) meetings and vendor check-ins to ensure seamless trial execution
Provide leadership in team development, process optimization, and clinical operations scale-up

Qualification

Oncology clinical diagnosticsMolecular biologyRegulatory knowledgeProject management toolsBudget managementQuality assuranceProblem-solving skillsCommunication skills

Required

Scientific Bachelor's a minimum; Master's (MBA/MS) preferred and PhD a plus
7+ years in oncology clinical diagnostics/therapeutic trials, with significant time in molecular pathology/genomics in a biotech/pharma/CRO environment
Proven experience in leading teams and managing complex operations. Willingness to perform tactical aspects of clinical operations
Familiar with all aspects of clinical trial diagnostics operations
Strong understanding of molecular biology, diagnostics, NGS and oncology
Regulatory knowledge (CAP, CLIA, IVDR)
Problem-solving and communication skills, competency in project management tools and MS applications
Quality assurance, budget management, and performance improvement

Benefits

Competitive Compensation and company wide benefits plan
Opportunities for career advancement and professional development.
A collaborative and innovative work environment dedicated to improving oncology outcomes.

Company

SAGA Diagnostics

twittertwittertwitter
company-logo
Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

Funding

Current Stage
Growth Stage
Total Funding
$17.96M
Key Investors
Hadean VenturesEASMESmiLe Incubator
2021-06-29Series A· $12.44M
2020-09-08Series Unknown
2019-06-11Series A· $4.23M
Company data provided by crunchbase